• Review the evidence supporting current frontline treatment modalities for metastatic RCC
  • Discuss ongoing investigational approaches in metastatic RCC
  • Examine the evidence for the role of metastatic site in treatment efficacy
Session date: 
04/23/2026 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Betul Gok Yavuz, MD, PhD